STRO

SUTRO BIOPHARMA INC

Healthcare | Micro Cap

-$1.93

EPS Forecast

$5.71

Revenue Forecast

Announcing earnings for the quarter ending 2026-09-30 soon

Proximilar's AI forecasts

EPS Forecast:

-$1.93

Revenue Forecast:

$5.71

EPS Surprise Forecast:

-$0.051

Revenue Surprise Forecast:

-$1

Post-release price volatility - Very high

Post-release Overnight Move:

±10.7%

Post-release 1-week Move:

±

Odds of beating consensus

Probability of beating EPS consensus:

47%

Probability of beating revenue consensus:

41%

Probability of beating both EPS & revs consensus:

25%

Probability of missing both EPS & revs consensus:

37%

Surprise rating (from -5 to 5)

How unusually large is the +/- surprise we forecast:

-4

Beta (β)

Forward Looking Beta (β):

1.02

Earnings volatility

EPS standard deviation:

$0.95

Revenue standard deviation:

$8

As % of share price:

6.23%

As % of market cap:

3.22% VERY HIGH

Confidence intervals and percentiles

EPS 95th %ile:

-$0.80

Revenue 95th %ile:

$15

EPS 75th %ile:

-$1.62

Revenue 75th %ile:

$8

EPS 25th %ile:

-$2.22

Revenue 25th %ile:

$4

EPS 5th %ile:

-$3.12

Revenue 5th %ile:

-$2

Correlation of surprises (strength of relationship)

Correlation between EPS & revenue surprises:

37% MEDIUM

Earnings sensitivity to revenue surprises (slope of regression line)

Expected % of revenue surprise going to EPS:

71% VERY HIGH

Stock's bid-ask spread

Bid-ask per $10K:

$55

Bid-ask per Share:

$0.08